LifeTech Scientific Corp
HKEX:1302

Watchlist Manager
LifeTech Scientific Corp Logo
LifeTech Scientific Corp
HKEX:1302
Watchlist
Price: 1.46 HKD 0.69% Market Closed
Market Cap: 6.4B HKD
Have any thoughts about
LifeTech Scientific Corp?
Write Note

LifeTech Scientific Corp
Income from Continuing Operations

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

LifeTech Scientific Corp
Income from Continuing Operations Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Income from Continuing Operations CAGR 3Y CAGR 5Y CAGR 10Y
LifeTech Scientific Corp
HKEX:1302
Income from Continuing Operations
ÂĄ80.6m
CAGR 3-Years
-36%
CAGR 5-Years
-11%
CAGR 10-Years
N/A
A
APT Medical Inc
SSE:688617
Income from Continuing Operations
ÂĄ522.1m
CAGR 3-Years
71%
CAGR 5-Years
99%
CAGR 10-Years
N/A
J
Jiangsu Yuyue Medical Equipment & Supply Co Ltd
SZSE:002223
Income from Continuing Operations
ÂĄ1.7B
CAGR 3-Years
3%
CAGR 5-Years
16%
CAGR 10-Years
19%
Shenzhen Mindray Bio-Medical Electronics Co Ltd
SZSE:300760
Income from Continuing Operations
ÂĄ12.4B
CAGR 3-Years
16%
CAGR 5-Years
23%
CAGR 10-Years
N/A
J
Jafron Biomedical Co Ltd
SZSE:300529
Income from Continuing Operations
ÂĄ794.1m
CAGR 3-Years
-11%
CAGR 5-Years
9%
CAGR 10-Years
N/A
Shanghai United Imaging Healthcare Co Ltd
SSE:688271
Income from Continuing Operations
ÂĄ2B
CAGR 3-Years
28%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

LifeTech Scientific Corp
Glance View

Market Cap
6.8B HKD
Industry
Health Care

LifeTech Scientific Corp. is an investment holding company, which engages in the development, manufacture, research, development and market of minimally invasive medical devices for cardiovascular and peripheral vascular diseases and disorders. The company is headquartered in Shenzhen, Guangdong and currently employs 943 full-time employees. The company went IPO on 2011-11-10. The firm operates through three business segments. The Congenital Heart Diseases Business segment is engaged in the research and development, manufacture and trading of devices related to congenital and structural heart diseases. The Peripheral Vascular Diseases Business segment is engaged in the research and development, manufacture and trading of devices related to peripheral vascular diseases. The Surgical Vascular Repair Business segment is engaged in the research and development, manufacture and trading of devices related to surgical vascular repair.

Intrinsic Value
2.06 HKD
Undervaluation 29%
Intrinsic Value
Price

See Also

What is LifeTech Scientific Corp's Income from Continuing Operations?
Income from Continuing Operations
80.6m CNY

Based on the financial report for Jun 30, 2024, LifeTech Scientific Corp's Income from Continuing Operations amounts to 80.6m CNY.

What is LifeTech Scientific Corp's Income from Continuing Operations growth rate?
Income from Continuing Operations CAGR 5Y
-11%

Over the last year, the Income from Continuing Operations growth was -75%. The average annual Income from Continuing Operations growth rates for LifeTech Scientific Corp have been -36% over the past three years , -11% over the past five years .

Back to Top